Phase II study of radiation therapy for isolated para-aoritc lymph node recurrence in patients with uterine cervical carcinoma

Phase II study of radiation therapy for isolated para-aoritc lymph node recurrence in patients with uterine cervical carcinoma - Phase II study of radiation therapy for isolated PALN in UCC

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000000904

Enrollment

Registered

2007-11-22

Start date

2007-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uterine cervical carcinoma

Interventions

radiation therapy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) pathological proven carcinoma 29 abdominal para-aoritc lymph node recurrence digagnosed by CT 3) no other recurrent sites than abdominal para-aoritc region 4) 20 <= Age < 80 5) PS: 0-2 6) no prior radiation therapy for adomen 7) adequate bone marrow function, renal function, hepatic function 8) written informed consent

Exclusion criteria

Exclusion criteria: 1) active double carcinoma exept carcinoma in situ 2) severe dementia 3) continous infusion and/or intake of steroids 4) severe complications 5) severe mental disorder 6) inappropriate judged by physicians

Design outcomes

Primary

Measure	Time frame
3-year overall survival	—

Secondary

Measure	Time frame
3-year progression-free survival, acute morbidity, proportion of ptorocl completion, late morbidity	—

Countries

Japan

Contacts

Public ContactYuzuru Niibe

Kitasato University School of Medicine Radiology

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026